Gastric Balloon – Procedure, Indications, Contraindications, Outcomes and Diet

The Orbera intragastric balloon is deployed via an endoscopic procedure, wherein the device is inserted through the oral cavity into the stomach, thereby eliminating the need for invasive surgical intervention. Throughout the process, the patient remains under the combined effects of general anesthesia and sedative medications, which ensures a complete absence of pain or discomfort. The total duration of the procedure typically ranges from 20 to 30 minutes, during which the medical professional meticulously positions the balloon within the gastric cavity and subsequently fills it with a sterile saline solution tailored to the patient’s specific requirements—most commonly between 500 and 750 milliliters in volume. Following the completion of the insertion, the patient is monitored in a clinical setting for a maximum of two hours until the healthcare team confirms stability and authorizes discharge. The primary objective of the intragastric balloon is to mechanically reduce the stomach’s capacity, thereby inducing an early sensation of satiety even after consuming significantly smaller food portions compared to previous dietary habits. The body’s adaptation to the presence of the foreign object within the stomach may span several days, during which transient symptoms such as nausea or a sensation of fullness may occur. Nevertheless, this adjustment period facilitates a gradual modification of eating behaviors and supports psychological adaptation in managing appetite. A critical safety feature of the procedure is the saline solution used to inflate the balloon, which is distinctly dyed with a bright blue pigment: in the event of a potential balloon leak, the fluid enters the gastrointestinal tract, absorbs into the bloodstream, and is eventually excreted via the kidneys, imparting a vivid blue hue to the urine. Such a color change serves as an unambiguous indicator for the patient to seek immediate medical evaluation. The procedure is predominantly performed in private specialty clinics, with associated costs ranging from five to ten thousand złoty, depending on the clinic’s reputation and the quality of the materials used in the balloon’s construction.

The insertion of an intragastric balloon represents one of the invasive yet reversible interventions for the management of morbid obesity and refractory excess weight, particularly when conventional therapeutic approaches—including dietary modification, enhanced physical activity, and pharmacotherapy—have proven ineffective. According to clinical guidelines, eligibility for the procedure is contingent upon meeting strictly defined criteria: a body mass index (BMI) exceeding 27 kg/m² and a total body weight at least 40% above the ideal range for the individual’s sex, age, and height. The decision to proceed with balloon placement is made by a multidisciplinary medical team, which evaluates both the patient’s physiological parameters and their commitment to subsequent lifestyle adjustments. It is critical to emphasize that the gastric balloon is not a cosmetic solution; its inappropriate use—for instance, to achieve rapid weight loss prior to social events—carries significant risks of complications and constitutes medical misuse.

The Orbera intragastric balloon procedure, while an established intervention for obesity management, is contraindicated in numerous patient populations due to stringent medical exclusion criteria. Absolute disqualifying factors include, but are not limited to, prior surgical interventions within the upper gastrointestinal tract, chronic or recurrent intestinal motility disorders—such as persistent constipation and irregular bowel movements—as well as diagnosed hiatal hernia or a history of acute peritonitis. Additionally, individuals with advanced renal, hepatic, or pulmonary pathologies, those undergoing prolonged hormonal or corticosteroid therapy, and patients demonstrating psychological resistance to sustained dietary and lifestyle modifications are deemed ineligible. Further exclusionary conditions encompass active substance abuse or alcohol dependence within the preceding twelve-month period, current pregnancy or lactation, and any documented neoplastic disease in the patient’s medical history.

Consistent adherence to individually tailored medical guidelines and nutritional specialist recommendations following the insertion of the Orbera intragastric balloon yields the intended therapeutic outcomes in the vast majority of cases. Multicenter analyses conducted under the auspices of Orbera’s international clinic network—encompassing a cohort of over 2,500 patients across European regions—demonstrated an average weight reduction of 20 kilograms. Concurrently, an independent study carried out in Brazil involving 323 participants recorded a mean weight loss of 15 kilograms, further corroborating the global efficacy of this interventional approach.

Prior to the Orbera gastric balloon implantation procedure, adherence to a 12-hour complete fast—including abstinence from all fluids—is an indispensable prerequisite to ensure the safety of the initial surgical phase. The post-implantation nutritional regimen is meticulously divided into distinct stages, with the first encompassing the three full days immediately following surgery. During this period, patients are restricted to a strictly liquid diet, which may include smooth fruit and vegetable juices, blended soups, clear broths, milk, and liquid gelatin desserts. Single-serving volumes must not exceed 100 milliliters, and consumption should proceed at a measured pace, avoiding extreme beverage temperatures while observing one-minute intervals between sips to mitigate the risk of nausea or vomiting. The recommended daily fluid intake during this phase is approximately two liters. Beginning in the second week post-procedure, the diet gradually transitions to semi-liquid (puréed) and soft foods, with emphasis on a phased approach and close monitoring of the body’s adaptive responses. Nutritional intake should prioritize high-protein, nutrient-dense options, and each shift in food consistency demands a period of adjustment. Once the body has acclimated to the new dietary pattern without digestive discomfort, softer foods—such as ripe bananas, tender fruits, semolina and millet porridge, oatmeal, plain yogurt, cottage cheese, eggs, and canned tuna or mackerel—may be incorporated. The final stage involves the gradual reintroduction of solid foods, though simple carbohydrates (white bread, white rice, pasta) should be avoided due to their potential to adhere to the balloon’s surface, fostering infections and halitosis. Maintaining optimal hydration and strictly adhering to the guidelines provided by the treating physician and dietitian are critical. The Orbera balloon represents one of the less invasive surgical interventions for obesity management, delivering rapid results through gastric volume reduction but accompanied by numerous medical contraindications and substantial procedural costs. A significant challenge lies in the risk of reverting to pre-existing dietary habits and experiencing weight regain (the "yo-yo effect") following balloon removal. This method appears most suitable for individuals committed to sustained lifestyle modifications—not solely through balloon placement but also via radical dietary overhaul and increased physical activity, which remain the most validated and effective strategies for combating excess weight.